Genetic Literacy and Communication of Genetic Information in Families Concerned with Hereditary Breast and Ovarian Cancer: A Cross-Study Comparison in Two Countries and within a Timeframe of More Than 10 Years.

family communication genetic affinity genetic counselling genetic information informing at-risk relatives knowledge of genetic risk factors sensitivity analysis

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
13 Dec 2021
Historique:
received: 06 11 2021
revised: 05 12 2021
accepted: 07 12 2021
entrez: 24 12 2021
pubmed: 25 12 2021
medline: 25 12 2021
Statut: epublish

Résumé

Examining genetic literacy in families concerned with hereditary breast and ovarian cancer (HBOC) helps understand how genetic information is passed on from individuals who had genetic counseling to their at-risk relatives. This cross-study comparison explored genetic literacy both at the individual and the family level using data collected from three sequential studies conducted in the U.S. and Switzerland over ≥10 years. Participants were primarily females, at-risk or confirmed carriers of HBOC-associated pathogenic variants, who had genetic counselling, and ≥1 of their relatives who did not. Fifteen items assessed genetic literacy. Among 1933 individuals from 518 families, 38.5% had genetic counselling and 61.5% did not. Although genetic literacy was higher among participants who had counselling, some risk factors were poorly understood. At the individual level, genetic literacy was associated with having counselling, ≤5 years ago, higher education, and family history of cancer. At the family level, genetic literacy was associated with having counselling, higher education, and a cancer diagnosis. The findings suggest that specific genetic information should be emphasized during consultations, and that at-risk relatives feel less informed about inherited cancer risk, even if information is shared within families. There is a need to increase access to genetic information among at-risk individuals.

Identifiants

pubmed: 34944873
pii: cancers13246254
doi: 10.3390/cancers13246254
pmc: PMC8699808
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Oncology Nursing Foundation
ID : 2007 Major Breast Cancer Research Award
Organisme : CDC HHS
ID : 5U48DP001901-03
Pays : United States
Organisme : Robert Wood Johnson Foundation, 2010 Nurse Faculty Scholars Award
ID : 68039
Organisme : Swiss Cancer League
ID : KLS-4294-08-2017
Organisme : Swiss Cancer Research Foundation
ID : KFS-5293-02-2021

Références

J Community Genet. 2019 Jan;10(1):73-84
pubmed: 29589204
Psychooncology. 2013 Jun;22(6):1336-43
pubmed: 22826208
Am J Obstet Gynecol. 2003 Oct;189(4 Suppl):S48-53
pubmed: 14586321
J Natl Cancer Inst Monogr. 2014 Nov;2014(49):145-86
pubmed: 25417231
Eur J Hum Genet. 2016 Mar;24(3):356-60
pubmed: 26130486
Cancer. 2017 Jul 1;123(13):2497-2505
pubmed: 28182268
Public Health Genomics. 2017;20(6):343-348
pubmed: 29852491
Genet Med. 2019 Jun;21(6):1363-1370
pubmed: 30385886
Genet Med. 2013 Aug;15(8):658-63
pubmed: 23448722
J Community Genet. 2019 Oct;10(4):481-487
pubmed: 30877488
Ann Surg Oncol. 2016 Sep;23(9):2795-801
pubmed: 27052646
Hered Cancer Clin Pract. 2011 May 19;9:2
pubmed: 21595959
J Genet Couns. 2020 Jun;29(3):410-422
pubmed: 31912597
Am J Med Genet C Semin Med Genet. 2018 Mar;178(1):98-107
pubmed: 29575600
Fam Cancer. 2001;1(3-4):135-41
pubmed: 14574169
JMIR Res Protoc. 2017 Sep 20;6(9):e184
pubmed: 28931501
JAMA. 2019 Aug 20;322(7):652-665
pubmed: 31429903
Breast. 2013 Aug;22(4):375-82
pubmed: 23673076
Public Health Genomics. 2011;14(4-5):279-89
pubmed: 20407217
Public Health Genomics. 2018;21(3-4):133-143
pubmed: 30808825
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
Genet Test Mol Biomarkers. 2013 Apr;17(4):327-35
pubmed: 23406207
J Health Commun. 2016;21 Suppl 1:58-68
pubmed: 27043759
Genet Med. 2008 Mar;10(3):167-72
pubmed: 18344705
J Genet Couns. 2016 Apr;25(2):258-69
pubmed: 26245632
J Health Commun. 2016;21(3):318-26
pubmed: 26192626
J Natl Cancer Inst. 2001 Oct 17;93(20):1520-2
pubmed: 11604472
Breast J. 2020 Apr;26(4):734-738
pubmed: 31659791
JAMA. 2015 Jun 2;313(21):2117-8
pubmed: 26034952
Genet Med. 2014 Jul;16(7):516-21
pubmed: 24357847
J Genet Couns. 2016 Apr;25(2):385-94
pubmed: 26306685
Public Health Genomics. 2011;14(4-5):201-10
pubmed: 21734434
Genet Med. 2008 Apr;10(4):251-8
pubmed: 18414207
Cancers (Basel). 2021 Feb 23;13(4):
pubmed: 33672149
BMC Cancer. 2013 Mar 01;13:97
pubmed: 23448100
Cancer Causes Control. 2017 Mar;28(3):191-201
pubmed: 28197806
Health Aff (Millwood). 2018 May;37(5):801-808
pubmed: 29733730

Auteurs

Carla Pedrazzani (C)

Department of Clinical Research, Faculty of Medicine, University of Basel, 4055 Basel, Switzerland.

Chang Ming (C)

Department of Clinical Research, Faculty of Medicine, University of Basel, 4055 Basel, Switzerland.

Nicole Bürki (N)

Women's Clinic, University Hospital Basel, 4031 Basel, Switzerland.

Maria Caiata-Zufferey (M)

Department of Business Economics, Health and Social Care, University of Applied Science and Arts of Southern Switzerland, 6928 Manno, Switzerland.

Pierre O Chappuis (PO)

Oncogenetics Unit, Service of Oncology, University Hospital of Geneva, 1205 Geneva, Switzerland.

Debra Duquette (D)

Feinberg School of Medicine, Northwestern University, Chicago, IL 60208, USA.

Karl Heinimann (K)

Medical Genetics, University Hospital Basel, 4031 Basel, Switzerland.

Viola Heinzelmann-Schwarz (V)

Women's Clinic, University Hospital Basel, 4031 Basel, Switzerland.

Rossella Graffeo-Galbiati (R)

Oncology Institute of Southern Switzerland, 6900 Lugano, Switzerland.

Sofia D Merajver (SD)

University of Michigan School of Public Health, Ann Arbor, MI 48109, USA.
Roger Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA.

Kara J Milliron (KJ)

Roger Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA.

Christian Monnerat (C)

Jura Hospital, 2800 Delémont, Switzerland.

Olivia Pagani (O)

Oncology Institute of Southern Switzerland, 6900 Lugano, Switzerland.

Manuela Rabaglio (M)

Inselspital University Hospital, 3010 Bern, Switzerland.

Maria C Katapodi (MC)

Department of Clinical Research, Faculty of Medicine, University of Basel, 4055 Basel, Switzerland.

Classifications MeSH